The study that 'should basically end any scientific debate' about masks
A massive randomized trial on how well masks hold up against symptomatic COVID-19 infections may be one of the most crucial studies of the coronavirus pandemic because it was able to solve the tricky issue of examining mask-wearing at a community level rather than an individual one.
The study involved launching pro-mask campaigns in some Bangladeshi villages, but not others, and the authors made two key findings. First, they determined that the public health interventions nearly tripled mask usage from 13 percent to 42 percent. Secondly, they discovered — by conducting sero-surveys backed up by interviews about COVID-19 symptoms and medical history — that masks did their job and reduced symptomatic infections in the communities that were subject to the campaigns by 9.3 percent. Jason Abaluck, an economist at Yale University who helped lead the study, told The Washington Post that figure would probably be higher if masking was universal.
There were a few other key notes in the study. Surgical masks were found to be particularly effective, while the jury is still out on cloth masks. And they were more effective in people older than 50, which could be explained by a few factors, including that young people were less likely to be symptomatic either way. They also may have been less compliant when it comes to masks.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Either way, Abaluck is pretty confident about the research, arguing that it "should basically end any scientific debate about whether masks can be effective in combating [COVID-19] at the population level" and calling it "a nail in the coffin" for anti-mask arguments. Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Why does Elon Musk take his son everywhere?
Talking Point With his four-year-old 'emotional support human' by his side, what message is the world's richest man sending?
By Rebekah Evans, The Week UK Published
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published